🇺🇸 FDA
Patent

US 10682393

Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

granted A61KA61K38/185

Quick answer

US patent 10682393 (Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions) held by United States Department of Veteran Affairs expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Department of Veteran Affairs
Grant date
Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/185